{"name":"Laboratorios Leti, S.L.","slug":"laboratorios-leti-s-l","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Cupressus arizonica","genericName":"Cupressus arizonica","slug":"cupressus-arizonica","indication":"Allergic rhinitis and/or allergic asthma caused by Cupressus arizonica (Arizona cypress) pollen sensitization","status":"marketed"},{"name":"Depigoid Parietaria judaica 1000DPP/ml","genericName":"Depigoid Parietaria judaica 1000DPP/ml","slug":"depigoid-parietaria-judaica-1000dpp-ml","indication":"Allergic rhinitis caused by Parietaria judaica pollen sensitization","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Artemisia vulgaris","genericName":"Artemisia vulgaris","slug":"artemisia-vulgaris","indication":"Allergic rhinitis and related allergic conditions","status":"marketed"}]}],"pipeline":[{"name":"Artemisia vulgaris","genericName":"Artemisia vulgaris","slug":"artemisia-vulgaris","phase":"marketed","mechanism":"Artemisia vulgaris is a herbal preparation that may exert anti-inflammatory and immunomodulatory effects through its volatile oils and sesquiterpene lactones.","indications":["Allergic rhinitis and related allergic conditions"],"catalyst":""},{"name":"Cupressus arizonica","genericName":"Cupressus arizonica","slug":"cupressus-arizonica","phase":"marketed","mechanism":"Cupressus arizonica pollen extract acts as an allergen immunotherapy agent that desensitizes the immune system to cypress pollen allergens through gradual exposure.","indications":["Allergic rhinitis and/or allergic asthma caused by Cupressus arizonica (Arizona cypress) pollen sensitization"],"catalyst":""},{"name":"Depigoid Parietaria judaica 1000DPP/ml","genericName":"Depigoid Parietaria judaica 1000DPP/ml","slug":"depigoid-parietaria-judaica-1000dpp-ml","phase":"phase_3","mechanism":"Depigoid is an allergen extract-based immunotherapeutic that desensitizes the immune system to Parietaria judaica pollen through gradual exposure, reducing allergic responses.","indications":["Allergic rhinitis caused by Parietaria judaica pollen sensitization","Allergic asthma associated with Parietaria judaica pollen allergy"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"marketed":2,"phase_3":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}